MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
On December 28, The National Safety Council released the 2023-2024 MSD Solutions Index Pledge Community Report, which revealed progress in addressing one of the most pervasive workplace injuries: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback